Kalvista Pharmaceuticals Inc (KALV) — Cash Flow-to-Debt Ratio
Kalvista Pharmaceuticals Inc (KALV) has a Cash Flow-to-Debt Ratio of -0.10x as of October 2025, meaning its operating cash flow of $-32.68 Million could theoretically repay 0% of its total liabilities ($322.93 Million) in one year. See cash generation quality of Kalvista Pharmaceuticals Inc to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Kalvista Pharmaceuticals Inc Cash Flow-to-Debt Ratio (2013–2025)
Historical debt coverage capacity for Kalvista Pharmaceuticals Inc across 16 annual periods. Also explore Kalvista Pharmaceuticals Inc (KALV) equity growth momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Kalvista Pharmaceuticals Inc (2013–2025)
Year-by-year debt coverage analysis for Kalvista Pharmaceuticals Inc. For market capitalisation and broader financial context, see Kalvista Pharmaceuticals Inc stock valuation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.98x | $-152.91 Million | $155.38 Million | ▲ +68.2% |
| 2024 | -3.10x | $-89.23 Million | $28.82 Million | ▲ +8.8% |
| 2023 | -3.39x | $-75.26 Million | $22.18 Million | ▲ +18.4% |
| 2022 | -4.16x | $-78.13 Million | $18.79 Million | ▼ -104.3% |
| 2021 | -2.04x | $-30.17 Million | $14.82 Million | ▲ +60.1% |
| 2020 | -5.11x | $-44.82 Million | $8.78 Million | ▼ -200.4% |
| 2019 | -1.70x | $-36.37 Million | $21.39 Million | ▼ -649.6% |
| 2018 | 0.31x | $10.56 Million | $34.14 Million | ▲ +103.9% |
| 2017 | -7.86x | $-23.72 Million | $3.02 Million | ▼ -94.1% |
| 2016 | -4.05x | $-13.16 Million | $3.25 Million | ▼ -426.0% |
| 2016 | -0.77x | $-5.08 Million | $6.60 Million | ▲ +72.4% |
| 2015 | -2.79x | $-20.86 Million | $7.48 Million | ▼ -2125.8% |
| 2015 | -0.13x | $-6.37 Million | $50.83 Million | ▲ +87.5% |
| 2014 | -1.00x | $-11.25 Million | $11.27 Million | ▼ -800.6% |
| 2014 | -0.11x | $-4.86 Million | $43.81 Million | ▼ -122.4% |
| 2013 | -0.05x | $-1.83 Million | $36.81 Million | — |